AbbVie (ABBV) Amortizatization of Intangibles (2012 - 2026)
AbbVie (ABBV) reported Amortizatization of Intangibles of $1.7 billion for Q1 2026, down 8.5% year-over-year from $1.9 billion in Q1 2025, and down 4.33% on a QoQ basis from $1.8 billion in Q4 2025.
AbbVie (ABBV) has 15 years of Amortizatization of Intangibles data on file, last reported at $1.7 billion in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 8.5% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 billion (down 3.39% YoY) and the FY2025 annual result came in at $7.4 billion, down 2.93% from the prior year.
- Amortizatization of Intangibles slipped to $1.7 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.1 billion in Q2 2023 and bottomed at $1.7 billion in Q1 2026.
- The 5-year median for Amortizatization of Intangibles is $1.9 billion (2024), against an average of $1.9 billion.
- The widest annual swing landed in 2022, when Amortizatization of Intangibles retreated 10.0%; it then grew 16.67% in 2023.
- Tracing ABBV's Amortizatization of Intangibles over 5 years: stood at $2.0 billion in 2022, then fell by 7.85% to $1.8 billion in 2023, then climbed by 1.68% to $1.9 billion in 2024, then decreased by 5.18% to $1.8 billion in 2025, then decreased by 4.33% to $1.7 billion in 2026.
- Per Business Quant, the three latest ABBV Amortizatization of Intangibles figures stand at $1.7 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 1.70 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 931.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 596.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Bn |
| Mar 31, 2026 | 1.70 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 1.90 Bn |
| Mar 31, 2025 | 1.86 Bn |
| Mar 31, 2025 | 1.86 Bn |
| Dec 31, 2024 | 1.87 Bn |
| Dec 31, 2024 | 1.87 Bn |
| Sep 30, 2024 | 1.90 Bn |
| Sep 30, 2024 | 1.90 Bn |
| Jun 30, 2024 | 1.90 Bn |
| Jun 30, 2024 | 1.90 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 1.84 Bn |
| Dec 31, 2023 | 1.84 Bn |
| Sep 30, 2023 | 2.00 Bn |
| Sep 30, 2023 | 2.00 Bn |
| Jun 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 2.10 Bn |
| Mar 31, 2023 | 1.95 Bn |
| Mar 31, 2023 | 1.95 Bn |
| Dec 31, 2022 | 2.00 Bn |
| Dec 31, 2022 | 2.00 Bn |
| Sep 30, 2022 | 2.00 Bn |
| Sep 30, 2022 | 2.00 Bn |
| Jun 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.80 Bn |
| Mar 31, 2022 | 1.86 Bn |
| Mar 31, 2022 | 1.86 Bn |
| Dec 31, 2021 | 1.80 Bn |
| Dec 31, 2021 | 1.80 Bn |
| Sep 30, 2021 | 1.90 Bn |
| Sep 30, 2021 | 1.90 Bn |
| Jun 30, 2021 | 2.00 Bn |
| Jun 30, 2021 | 2.00 Bn |
| Mar 31, 2021 | 2.01 Bn |
| Mar 31, 2021 | 2.01 Bn |
| Dec 31, 2020 | 4.00 Bn |
| Dec 31, 2020 | 4.00 Bn |
| Sep 30, 2020 | 2.10 Bn |
| Sep 30, 2020 | 2.10 Bn |
| Jun 30, 2020 | 1.40 Bn |
| Jun 30, 2020 | 1.40 Bn |
| Mar 31, 2020 | 444.00 Mn |
| Mar 31, 2020 | 444.00 Mn |
| Dec 31, 2019 | 353.00 Mn |
| Dec 31, 2019 | 353.00 Mn |
| Sep 30, 2019 | 389.00 Mn |
| Sep 30, 2019 | 389.00 Mn |
| Jun 30, 2019 | 388.00 Mn |
| Jun 30, 2019 | 388.00 Mn |
| Mar 31, 2019 | 385.00 Mn |
| Mar 31, 2019 | 385.00 Mn |
| Dec 31, 2018 | 326.00 Mn |
| Dec 31, 2018 | 326.00 Mn |
| Sep 30, 2018 | 320.00 Mn |
| Sep 30, 2018 | 320.00 Mn |
| Jun 30, 2018 | 324.00 Mn |
| Jun 30, 2018 | 324.00 Mn |
| Mar 31, 2018 | 330.00 Mn |
| Mar 31, 2018 | 330.00 Mn |
| Dec 31, 2017 | 292.00 Mn |
| Dec 31, 2017 | 292.00 Mn |
| Sep 30, 2017 | 268.00 Mn |
| Sep 30, 2017 | 268.00 Mn |
| Jun 30, 2017 | 269.00 Mn |
| Jun 30, 2017 | 269.00 Mn |
| Mar 31, 2017 | 271.00 Mn |
| Mar 31, 2017 | 271.00 Mn |
| Dec 31, 2016 | 210.00 Mn |
| Dec 31, 2016 | 210.00 Mn |
| Sep 30, 2016 | 208.00 Mn |
| Sep 30, 2016 | 208.00 Mn |
| Jun 30, 2016 | 181.00 Mn |
| Jun 30, 2016 | 181.00 Mn |
| Mar 31, 2016 | 165.00 Mn |
| Mar 31, 2016 | 165.00 Mn |
| Dec 31, 2015 | 140.00 Mn |
| Dec 31, 2015 | 140.00 Mn |
| Sep 30, 2015 | 125.00 Mn |
| Sep 30, 2015 | 125.00 Mn |
| Jun 30, 2015 | 86.00 Mn |
| Jun 30, 2015 | 86.00 Mn |
| Mar 31, 2015 | 68.00 Mn |
| Mar 31, 2015 | 68.00 Mn |
| Dec 31, 2014 | 96.00 Mn |
| Dec 31, 2014 | 96.00 Mn |
| Sep 30, 2014 | 98.00 Mn |
| Sep 30, 2014 | 98.00 Mn |
| Jun 30, 2014 | 99.00 Mn |
| Jun 30, 2014 | 99.00 Mn |
| Mar 31, 2014 | 110.00 Mn |
| Mar 31, 2014 | 110.00 Mn |
| Dec 31, 2013 | 101.00 Mn |
| Dec 31, 2013 | 101.00 Mn |
| Sep 30, 2013 | 137.00 Mn |
| Sep 30, 2013 | 137.00 Mn |
| Jun 30, 2013 | 136.00 Mn |
| Jun 30, 2013 | 136.00 Mn |
| Mar 31, 2013 | 135.00 Mn |
| Mar 31, 2013 | 135.00 Mn |
| Dec 31, 2012 | 136.00 Mn |
| Dec 31, 2012 | 136.00 Mn |
| Sep 30, 2012 | 134.00 Mn |
| Sep 30, 2012 | 134.00 Mn |
| Jun 30, 2012 | 176.00 Mn |
| Jun 30, 2012 | 176.00 Mn |
| Mar 31, 2012 | 179.00 Mn |
| Mar 31, 2012 | 179.00 Mn |